{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:41:45Z","timestamp":1792460505961,"version":"4.5.0"},"reference-count":201,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s43440-025-00786-7","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:19:12Z","timestamp":1758759552000},"page":"173-193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Current advances in the management of hepatic encephalopathy: an updated and critical review"],"prefix":"10.1007","volume":"78","author":[{"given":"Bilal","family":"El-Mansoury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hicham","family":"Esselmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Merzouki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezhilarasan","family":"Devaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar El","family":"Hiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Najimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"issue":"4","key":"786_CR1","first-page":"228","volume":"13","author":"XY Tong","year":"2024","unstructured":"Tong XY, Hussain H, Shamaladevi N, Norenberg MD, Fadel A, El Hiba O, et al. Age and sex in the development of hepatic encephalopathy: role of alcohol. Biology (Basel). 2024;13(4):228.","journal-title":"Biology (Basel)"},{"key":"786_CR2","doi-asserted-by":"publisher","first-page":"105866","DOI":"10.1016\/j.neuint.2024.105866","volume":"180","author":"XY Tong","year":"2024","unstructured":"Tong XY, Norenberg MD, Paidas MJ, Shamaladevi N, Salgueiro L, Jaszberenyi M, et al. Mechanism of alzheimer type II astrocyte development in hepatic encephalopathy. Neurochem Int. 2024;180:105866.","journal-title":"Neurochem Int"},{"issue":"7","key":"786_CR3","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/j.1365-2036.2011.04590.x","volume":"33","author":"JS Bajaj","year":"2011","unstructured":"Bajaj JS, Cordoba J, Mullen KD, Amodio P, Shawcross DL, Butterworth RF, et al. The design of clinical trials in hepatic encephalopathy\u2013an international society for hepatic encephalopathy and nitrogen metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther. 2011;33(7):739\u201347.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"786_CR4","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.cgh.2019.08.047","volume":"18","author":"RK Dhiman","year":"2020","unstructured":"Dhiman RK, Thumburu KK, Verma N, Chopra M, Rathi S, Dutta U, et al. Comparative efficacy of treatment options for minimal hepatic encephalopathy: a systematic review and network meta-analysis. Clin Gastroenterol Hepatol. 2020;18(4):800\u201312.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"786_CR5","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1080\/13543784.2023.2277386","volume":"32","author":"T Balzano","year":"2023","unstructured":"Balzano T, Llansola M, Arenas YM, Izquierdo-Altarejos P, Felipo V. Hepatic encephalopathy: investigational drugs in preclinical and early phase development. Expert Opin Investig Drugs. 2023;32(11):1055\u201369.","journal-title":"Expert Opin Investig Drugs"},{"issue":"12","key":"786_CR6","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1002\/lt.23981","volume":"20","author":"RJ Wong","year":"2014","unstructured":"Wong RJ, Gish RG, Ahmed A. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation. Liver Transpl. 2014;20(12):1454\u201361.","journal-title":"Liver Transpl"},{"key":"786_CR7","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1097\/01.aids.0000192076.03443.6d","volume":"19","author":"K Weissenborn","year":"2005","unstructured":"Weissenborn K, Bokemeyer M, Krause J, Ennen J, Ahl B. Neurological and neuropsychiatric syndromes associated with liver disease. AIDS. 2005;19:S93\u20138.","journal-title":"AIDS"},{"key":"786_CR8","doi-asserted-by":"crossref","unstructured":"Lizardi-cervera J, Almeda P, Guevara L, Uribe M. Hepatic encephalopathy: a review. Ann Hepatol. 2003;2(3).","DOI":"10.1016\/S1665-2681(19)32137-4"},{"issue":"4","key":"786_CR9","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jhep.2012.11.043","volume":"58","author":"AB Tryc","year":"2013","unstructured":"Tryc AB, Goldbecker A, Berding G, R\u00fcmke S, Afshar K, Shahrezaei GH, et al. Cirrhosis-related parkinsonism: Prevalence, mechanisms and response to treatments. J Hepatol. 2013;58(4):698\u2013705.","journal-title":"J Hepatol"},{"issue":"2","key":"786_CR10","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/hep.27210","volume":"60","author":"H Vilstrup","year":"2014","unstructured":"Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, et al. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American association for the study of liver diseases and the European association for the study of the liver. Hepatology. 2014;60(2):715\u201335.","journal-title":"Hepatology"},{"key":"786_CR11","doi-asserted-by":"publisher","unstructured":"Meena BL, Narayan SJA, Sarin SK. Hepatic encephalopathy in non-cirrhotic portal hypertension. Metab Brain Dis [Internet]. 2025;40(1):103. Available from: https:\/\/doi.org\/10.1007\/s11011-024-01522-5","DOI":"10.1007\/s11011-024-01522-5"},{"issue":"8","key":"786_CR12","first-page":"514","volume":"20","author":"K Mumtaz","year":"2010","unstructured":"Mumtaz K, Ahmed US, Abid S, Baig N, Hamid S, Jafri W. Precipitating factors and the outcome of hepatic encephalopathy in liver cirrhosis. J Coll Physicians Surg Pakistan. 2010;20(8):514.","journal-title":"J Coll Physicians Surg Pakistan"},{"key":"786_CR13","doi-asserted-by":"crossref","unstructured":"Kabaria S, Dalal I, Gupta K, Bhurwal A, Carlos, Minacapelli D, et al. Hepatic encephalopathy: a review. Hepatology. 2021.","DOI":"10.33590\/emjhepatol\/21-00030"},{"key":"786_CR14","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10620-007-9895-0","volume":"53","author":"TI Hassanein","year":"2008","unstructured":"Hassanein TI, Hilsabeck RC, Perry W. Introduction to the hepatic encephalopathy scoring algorithm (HESA). Dig Dis Sci. 2008;53:529\u201338.","journal-title":"Dig Dis Sci"},{"issue":"6","key":"786_CR15","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/j.1365-2036.2007.03394.x","volume":"26","author":"M Ortiz","year":"2007","unstructured":"Ortiz M, Cordoba J, Doval E, Jacas C, Pujadas F, Esteban R, et al. Development of a clinical hepatic encephalopathy staging scale. Aliment Pharmacol Ther. 2007;26(6):859\u201367.","journal-title":"Aliment Pharmacol Ther"},{"key":"786_CR16","doi-asserted-by":"publisher","unstructured":"Rose CF, Amodio P, Bajaj JS, Dhiman RK, Montagnese S, Taylor-Robinson SD, et al. Hepatic encephalopathy: novel insights into classification, pathophysiology and therapy. J Hepatol [Internet]. 2020;73(6):1526\u201347. Available from: https:\/\/doi.org\/10.1016\/j.jhep.2020.07.013","DOI":"10.1016\/j.jhep.2020.07.013"},{"issue":"2","key":"786_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1478-3231.2010.02302.x","volume":"31","author":"G Wright","year":"2011","unstructured":"Wright G, Noiret L, Olde Damink SWM, Jalan R. Interorgan ammonia metabolism in liver failure: the basis of current and future therapies. Liver Int. 2011;31(2):163\u201375.","journal-title":"Liver Int"},{"issue":"8","key":"786_CR18","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.cgh.2012.04.011","volume":"10","author":"R Kumar","year":"2012","unstructured":"Kumar R, Sharma H, Prakash S, Panda SK, Khanal S, Acharya SK. Persistent hyperammonemia is associated with complications and poor outcomes in patients with acute liver failure. Clin Gastroenterol Hepatol. 2012;10(8):925\u201331.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"786_CR19","doi-asserted-by":"publisher","unstructured":"Rackayova V, Braissant O, Rougemont AL, Cudalbu C, McLin VA. Longitudinal osmotic and neurometabolic changes in young rats with chronic cholestatic liver disease. Sci Rep [Internet]. 2020;10(1):7536. Available from: https:\/\/doi.org\/10.1038\/s41598-020-64416-3","DOI":"10.1038\/s41598-020-64416-3"},{"issue":"3","key":"786_CR20","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S0002-9343(02)01477-8","volume":"114","author":"JP Ong","year":"2003","unstructured":"Ong JP, Aggarwal A, Krieger D, Easley KA, Karafa MT, Van Lente F, et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med. 2003;114(3):188\u201393.","journal-title":"Am J Med"},{"issue":"6","key":"786_CR21","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s11011-015-9746-1","volume":"31","author":"RF Butterworth","year":"2016","unstructured":"Butterworth RF. Pathogenesis of hepatic encephalopathy in cirrhosis: the concept of synergism revisited. Metab Brain Dis. 2016;31(6):1211\u20135.","journal-title":"Metab Brain Dis"},{"issue":"2","key":"786_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0168-8278(95)80424-2","volume":"22","author":"RS Lin","year":"1995","unstructured":"Lin RS, Lee FY, Lee SD, Tsai YT, Lin HC, Rei-Hwa L, et al. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophaegeal varices, and hyperdynamic circulation. J Hepatol. 1995;22(2):165\u201372.","journal-title":"J Hepatol"},{"issue":"4","key":"786_CR23","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1053\/jhep.2000.17687","volume":"32","author":"N Rolando","year":"2000","unstructured":"Rolando N, Wade JIM, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology. 2000;32(4):734\u20139.","journal-title":"Hepatology"},{"key":"786_CR24","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.jceh.2014.07.006","volume":"5","author":"AR Jayakumar","year":"2015","unstructured":"Jayakumar AR, Rao KVR, Norenberg MD. Neuroinflammation in hepatic encephalopathy: mechanistic aspects. J Clin Exp Hepatol. 2015;5:S21\u20138.","journal-title":"J Clin Exp Hepatol"},{"issue":"1","key":"786_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/hep.24326","volume":"54","author":"I Zemtsova","year":"2011","unstructured":"Zemtsova I, G\u00f6rg B, Keitel V, Bidmon HJ, Schr\u00f6r K, H\u00e4ussinger D. Microglia activation in hepatic encephalopathy in rats and humans. Hepatology. 2011;54(1):204\u201315.","journal-title":"Hepatology"},{"key":"786_CR26","doi-asserted-by":"crossref","unstructured":"Choi K, Cho Y, Chae Y, Cheon SY. Cell\u2013cell communications in the brain of hepatic encephalopathy: the neurovascular unit. Life Sci. 2025;123413.","DOI":"10.1016\/j.lfs.2025.123413"},{"issue":"4","key":"786_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/metabo14040193","volume":"14","author":"B El-Mansoury","year":"2024","unstructured":"El-Mansoury B, Smimih K, El Khiat A, Draoui A, Aimrane A, Chatoui R, et al. Short working memory impairment associated with hippocampal microglia activation in chronic hepatic encephalopathy. Metabolites. 2024;14(4):193.","journal-title":"Metabolites"},{"issue":"1","key":"786_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-016-0505-y","volume":"13","author":"V Hern\u00e1ndez-Rabaza","year":"2016","unstructured":"Hern\u00e1ndez-Rabaza V, Cabrera-Pastor A, Taoro-Gonz\u00e1lez L, Malaguarnera M, Agust\u00ed A, Llansola M, et al. Hyperammonemia induces glial activation, neuroinflammation and alters neurotransmitter receptors in hippocampus, impairing Spatial learning: reversal by Sulforaphane. J Neuroinflammation. 2016;13(1):1\u201311.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"786_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.neuint.2009.11.010","volume":"56","author":"C B\u00e9meur","year":"2010","unstructured":"B\u00e9meur C, Qu H, Desjardins P, Butterworth RF. IL-1 or TNF receptor gene deletion delays onset of encephalopathy and attenuates brain edema in experimental acute liver failure. Neurochem Int. 2010;56(2):213\u20135.","journal-title":"Neurochem Int"},{"issue":"2","key":"786_CR30","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1053\/j.gastro.2010.03.040","volume":"139","author":"R Rodrigo","year":"2010","unstructured":"Rodrigo R, Cauli O, Gomez\u2013Pinedo U, Agusti A, Hernandez\u2013Rabaza V, Garcia\u2013Verdugo J, et al. Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy. Gastroenterology. 2010;139(2):675\u201384.","journal-title":"Gastroenterology"},{"issue":"1","key":"786_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11011-010-9177-y","volume":"25","author":"C Bemeur","year":"2010","unstructured":"Bemeur C, Desjardins P, Butterworth RF. Evidence for oxidative\/nitrosative stress in the pathogenesis of hepatic encephalopathy. Metab Brain Dis. 2010;25(1):3\u20139.","journal-title":"Metab Brain Dis"},{"key":"786_CR32","doi-asserted-by":"crossref","unstructured":"O\u2019Connor JE, Costell M. New roles of carnitine metabolism in ammonia cytotoxicity. Cirrhosis Hepatic Enceph Ammonium Toxic. 1990;183\u201395.","DOI":"10.1007\/978-1-4684-5826-8_12"},{"issue":"5","key":"786_CR33","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jhep.2019.06.020","volume":"71","author":"B G\u00f6rg","year":"2019","unstructured":"G\u00f6rg B, Karababa A, Sch\u00fctz E, Paluschinski M, Schrimpf A, Shafigullina A, et al. O-GlcNAcylation-dependent upregulation of HO1 triggers ammonia-induced oxidative stress and senescence in hepatic encephalopathy. J Hepatol. 2019;71(5):930\u201341.","journal-title":"J Hepatol"},{"issue":"1","key":"786_CR34","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/hep.23656","volume":"52","author":"B G\u00f6rg","year":"2010","unstructured":"G\u00f6rg B, Qvartskhava N, Bidmon HJ, Palomero-Gallagher N, Kircheis G, Zilles K, et al. Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy. Hepatology. 2010;52(1):256\u201365.","journal-title":"Hepatology"},{"key":"786_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s11011-017-0136-8","volume":"33","author":"S Dhanda","year":"2018","unstructured":"Dhanda S, Sunkaria A, Halder A, Sandhir R. Mitochondrial dysfunctions contribute to energy deficits in rodent model of hepatic encephalopathy. Metab Brain Dis. 2018;33:209\u201323.","journal-title":"Metab Brain Dis"},{"key":"786_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.freeradbiomed.2021.12.011","volume":"178","author":"K Pierzchala","year":"2022","unstructured":"Pierzchala K, Simicic D, Sienkiewicz A, Sessa D, Mitrea S, Braissant O, et al. Central nervous system and systemic oxidative stress interplay with inflammation in a bile duct ligation rat model of type C hepatic encephalopathy. Free Radic Biol Med. 2022;178:295\u2013307.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"786_CR37","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/01.jnen.0000200152.98259.4e","volume":"65","author":"E Chroni","year":"2006","unstructured":"Chroni E, Patsoukis N, Karageorgos N, Konstantinou D, Georgiou C. Brain oxidative stress induced by obstructive jaundice in rats. J Neuropathol Exp Neurol. 2006;65(2):193\u20138.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"786_CR38","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jhep.2019.05.022","volume":"71","author":"O Braissant","year":"2019","unstructured":"Braissant O, Rackayov\u00e1 V, Pierzchala K, Grosse J, McLin VA, Cudalbu C. Longitudinal neurometabolic changes in the hippocampus of a rat model of chronic hepatic encephalopathy. J Hepatol. 2019;71(3):505\u201315.","journal-title":"J Hepatol"},{"issue":"7","key":"786_CR39","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuint.2009.06.001","volume":"55","author":"W Jiang","year":"2009","unstructured":"Jiang W, Desjardins P, Butterworth RF. Minocycline attenuates oxidative\/nitrosative stress and cerebral complications of acute liver failure in rats. Neurochem Int. 2009;55(7):601\u20135.","journal-title":"Neurochem Int"},{"issue":"1\u20133","key":"786_CR40","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.neuint.2009.02.007","volume":"55","author":"W Jiang","year":"2009","unstructured":"Jiang W, Desjardins P, Butterworth RF. Hypothermia attenuates oxidative\/nitrosative stress, encephalopathy and brain edema in acute (ischemic) liver failure. Neurochem Int. 2009;55(1\u20133):124\u20138.","journal-title":"Neurochem Int"},{"issue":"1\u20133","key":"786_CR41","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.neuint.2009.01.023","volume":"55","author":"K Sawara","year":"2009","unstructured":"Sawara K, Desjardins P, Chatauret N, Kato A, Suzuki K, Butterworth RF. Alterations in expression of genes coding for proteins of the neurovascular unit in ischemic liver failure. Neurochem Int. 2009;55(1\u20133):119\u201323.","journal-title":"Neurochem Int"},{"issue":"5","key":"786_CR42","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1177\/1756283X16645049","volume":"9","author":"N Mousa","year":"2016","unstructured":"Mousa N, Abdel-Razik A, Zaher A, Hamed M, Shiha G, Effat N, et al. The role of antioxidants and zinc in minimal hepatic encephalopathy: a randomized trial. Th Adv Gastroenterol. 2016;9(5):684\u201391.","journal-title":"Th Adv Gastroenterol"},{"issue":"5","key":"786_CR43","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.tice.2013.06.001","volume":"45","author":"HN Mustafa","year":"2013","unstructured":"Mustafa HN, El Awdan SA, Hegazy GA. Protective role of antioxidants on thioacetamide-induced acute hepatic encephalopathy: biochemical and ultrastructural study. Tissue Cell. 2013;45(5):350\u201362.","journal-title":"Tissue Cell"},{"issue":"1","key":"786_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0168-8278(99)80160-3","volume":"31","author":"R Bruck","year":"1999","unstructured":"Bruck R, Aeed H, Shirin H, Matas Z, Zaidel L, Avni Y, et al. The hydroxyl radical scavengers dimethylsulfoxide and dimethylthiourea protect rats against thioacetamide-induced fulminant hepatic failure. J Hepatol. 1999;31(1):27\u201338.","journal-title":"J Hepatol"},{"issue":"5","key":"786_CR45","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/0016-5085(87)90571-3","volume":"93","author":"ML Bassett","year":"1987","unstructured":"Bassett ML, Mullen KD, Skolnick P, Jones EA. Amelioration of hepatic encephalopathy by Pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure. Gastroenterology. 1987;93(5):1069\u201377.","journal-title":"Gastroenterology"},{"issue":"5","key":"786_CR46","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/j.1471-4159.1984.tb02816.x","volume":"42","author":"P Ferenci","year":"1984","unstructured":"Ferenci P, Jacobs R, Pappas SC, Schafer DF, Jones EA. Enzymes of cerebral GABA metabolism and synaptosomal GABA uptake in acute liver failure in the rabbit: evidence for decreased cerebral GABA-transaminase activity. J Neurochem. 1984;42(5):1487\u201390.","journal-title":"J Neurochem"},{"key":"786_CR47","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/BF00968397","volume":"17","author":"U Wysmyk","year":"1992","unstructured":"Wysmyk U, Oja SS, Saransaari P, Albrecht J. Enhanced GABA release in cerebral cortical slices derived from rats with thioacetamide-induced hepatic encephalopathy. Neurochem Res. 1992;17:1187\u201390.","journal-title":"Neurochem Res"},{"issue":"4","key":"786_CR48","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1136\/gut.46.4.546","volume":"46","author":"R Jalan","year":"2000","unstructured":"Jalan R, Turjanski N, Taylor-Robinson SD, Koepp MJ, Richardson MP, Wilson JA, et al. Increased availability of central benzodiazepine receptors in patients with chronic hepatic encephalopathy and alcohol related cirrhosis. Gut. 2000;46(4):546\u201352.","journal-title":"Gut"},{"key":"786_CR49","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1023\/A:1021949616422","volume":"17","author":"EA Jones","year":"2002","unstructured":"Jones EA. Ammonia, the GABA neurotransmitter system, and hepatic encephalopathy. Metab Brain Dis. 2002;17:275\u201381.","journal-title":"Metab Brain Dis"},{"issue":"4","key":"786_CR50","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1053\/j.gastro.2008.12.057","volume":"136","author":"O Cauli","year":"2009","unstructured":"Cauli O, Mansouri MT, Agusti A, Felipo V. Hyperammonemia increases GABAergic tone in the cerebellum but decreases it in the rat cortex. Gastroenterology. 2009;136(4):1359\u201367.","journal-title":"Gastroenterology"},{"issue":"1","key":"786_CR51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0304-3940(93)90043-K","volume":"151","author":"K Takahashi","year":"1993","unstructured":"Takahashi K, Kameda H, Kataoka M, Sanjou K, Harata N, Akaike N. Ammonia potentiates GABAA response in dissociated rat cortical neurons. Neurosci Lett. 1993;151(1):51\u20134.","journal-title":"Neurosci Lett"},{"key":"786_CR52","first-page":"312","volume":"66","author":"TC Quint\u00e3o","year":"2012","unstructured":"Quint\u00e3o TC, Rabelo LM, Alvarez TGS, Guimar\u00e3es AT, Rodrigues ASL, Cardoso LS, et al. Zebrafish protocols for neurobehavioral research. Chemosphere. 2012;66:312\u201324.","journal-title":"Chemosphere"},{"issue":"5","key":"786_CR53","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/j.1471-4159.2011.07244.x","volume":"117","author":"R Leke","year":"2011","unstructured":"Leke R, Bak LK, Iversen P, S\u00f8rensen M, Keiding S, Vilstrup H, et al. Synthesis of neurotransmitter GABA via the neuronal Tricarboxylic acid cycle is elevated in rats with liver cirrhosis consistent with a high GABAergic tone in chronic hepatic encephalopathy. J Neurochem. 2011;117(5):824\u201332.","journal-title":"J Neurochem"},{"key":"786_CR54","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jsbmb.2015.11.006","volume":"160","author":"RF Butterworth","year":"2016","unstructured":"Butterworth RF. Neurosteroids in hepatic encephalopathy: novel insights and new therapeutic opportunities. J Steroid Biochem Mol Biol. 2016;160:94\u20137.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"786_CR55","doi-asserted-by":"publisher","unstructured":"Jones EA, Mullen KD. Theories of the pathogenesis of hepatic encephalopathy. Clin Liver Dis [Internet]. 2012;16(1):7\u201326. Available from: https:\/\/doi.org\/10.1016\/j.cld.2011.12.010","DOI":"10.1016\/j.cld.2011.12.010"},{"issue":"3","key":"786_CR56","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/hep.510310322","volume":"31","author":"C Hermenegildo","year":"2000","unstructured":"Hermenegildo C, Monfort P, Felipo V. Activation of N-methyl\u2010D\u2010aspartate receptors in rat brain in vivo following acute ammonia intoxication: characterization by in vivo brain Microdialysis. Hepatology. 2000;31(3):709\u201315.","journal-title":"Hepatology"},{"issue":"6\u20137","key":"786_CR57","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.neuint.2005.10.014","volume":"48","author":"R Rodrigo","year":"2006","unstructured":"Rodrigo R, Felipo V. Brain regional alterations in the modulation of the glutamate\u2013nitric oxide-cGMP pathway in liver cirrhosis: role of hyperammonemia and cell types involved. Neurochem Int. 2006;48(6\u20137):472\u20137.","journal-title":"Neurochem Int"},{"issue":"7715","key":"786_CR58","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(71)92048-4","volume":"298","author":"J Fischer","year":"1971","unstructured":"Fischer J, Baldessarini R. False neurotransmitters and hepatic failure. Lancet. 1971;298(7715):75\u201380.","journal-title":"Lancet"},{"issue":"4","key":"786_CR59","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S0002-9610(02)00808-5","volume":"183","author":"JH James","year":"2002","unstructured":"James JH. Branched chain amino acids in heptatic encephalopathy. Am J Surg. 2002;183(4):424\u20139.","journal-title":"Am J Surg"},{"issue":"11","key":"786_CR60","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1136\/gut.19.11.1068","volume":"19","author":"MY Morgan","year":"1978","unstructured":"Morgan MY, Milsom JP, Sherlock S. Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease. Gut. 1978;19(11):1068\u201373.","journal-title":"Gut"},{"key":"786_CR61","doi-asserted-by":"crossref","unstructured":"El Hiba O, El-Mansoury B, Norenberg M, Jayakumar AR. Astroglia and acute hepatic encephalopathy: the mechanisms of cytotoxic brain edema. In: physiology and function of glial cells in health and disease. IGI Global. 2024:243\u201360.","DOI":"10.4018\/978-1-6684-9675-6.ch013"},{"key":"786_CR62","doi-asserted-by":"publisher","unstructured":"Aldridge DR, Tranah EJ, Shawcross DL. Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation. J Clin Exp Hepatol [Internet]. 2015;5(S1):S7\u201320. Available from: https:\/\/doi.org\/10.1016\/j.jceh.2014.06.004","DOI":"10.1016\/j.jceh.2014.06.004"},{"issue":"1","key":"786_CR63","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/hep.1840190114","volume":"19","author":"S Aggarwal","year":"1994","unstructured":"Aggarwal S, Kramer D, Yonas H, Obrist W, Kang Y, Martin M, et al. Cerebral hemodynamic and metabolic changes in fulminant hepatic failure: a retrospective study. Hepatology. 1994;19(1):80\u20137.","journal-title":"Hepatology"},{"issue":"2","key":"786_CR64","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.neuroimage.2010.04.260","volume":"52","author":"MJ Poveda","year":"2010","unstructured":"Poveda MJ, Bernabeu \u00c1, Concepci\u00f3n L, Roa E, de Madaria E, Zapater P, et al. Brain edema dynamics in patients with overt hepatic encephalopathy: a magnetic resonance imaging study. NeuroImage. 2010;52(2):481\u20137.","journal-title":"NeuroImage"},{"issue":"4","key":"786_CR65","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/hep.21114","volume":"43","author":"RA Kale","year":"2006","unstructured":"Kale RA, Gupta RK, Saraswat VA, Hasan KM, Trivedi R, Mishra AM, et al. Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology. 2006;43(4):698\u2013706.","journal-title":"Hepatology"},{"issue":"8","key":"786_CR66","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.3174\/ajnr.A2533","volume":"32","author":"L Chavarria","year":"2011","unstructured":"Chavarria L, Alonso J, Garcia-Martinez R, Aymerich FX, Huerga E, Jacas C, et al. Biexponential analysis of diffusion-tensor imaging of the brain in patients with cirrhosis before and after liver transplantation. Am J Neuroradiol. 2011;32(8):1510\u20137.","journal-title":"Am J Neuroradiol"},{"issue":"3","key":"786_CR67","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jhep.2013.10.011","volume":"60","author":"CR Bosoi","year":"2014","unstructured":"Bosoi CR, Zwingmann C, Marin H, Parent-Robitaille C, Huynh J, Tremblay M, et al. Increased brain lactate is central to the development of brain edema in rats with chronic liver disease. J Hepatol. 2014;60(3):554\u201360.","journal-title":"J Hepatol"},{"key":"786_CR68","doi-asserted-by":"crossref","unstructured":"Gelpi E, Rahimi J, Klotz S, Schmid S, Ricken G, Forcen-vega S, et al. The autophagic marker p62 highlights alzheimer type II astrocytes in metabolic \/ hepatic encephalopathy. Neuropathology. 2020;358\u201366.","DOI":"10.1111\/neup.12660"},{"issue":"11","key":"786_CR69","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1023\/A:1022532623281","volume":"24","author":"H Chan","year":"1999","unstructured":"Chan H, Butterworth RF. Evidence for an astrocytic glutamate transporter deficit in hepatic encephalopathy. Neurochem Res. 1999;24(11):1397\u2013401.","journal-title":"Neurochem Res"},{"key":"786_CR70","doi-asserted-by":"crossref","unstructured":"Agarwal AN, Mais DD. Sensitivity and specificity of alzheimer type II astrocytes in hepatic encephalopathy. 2020;(May 2019).","DOI":"10.5858\/arpa.2018-0455-OA"},{"issue":"3","key":"786_CR71","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neulet.2005.11.064","volume":"396","author":"AS Hazell","year":"2006","unstructured":"Hazell AS, Normandin L, Norenberg MD, Kennedy G, Yi JH. Alzheimer type II astrocytic changes following sub-acute exposure to manganese and its prevention by antioxidant treatment. Neurosci Lett. 2006;396(3):167\u201371.","journal-title":"Neurosci Lett"},{"issue":"6","key":"786_CR72","first-page":"618","volume":"36","author":"MD Norenberg","year":"1977","unstructured":"Norenberg MD. A light and electron microscopic study of experimental portal-systemic (ammonia) encephalopathy. Progression and reversal of the disorder. Lab Invest. 1977;36(6):618\u201327.","journal-title":"Lab Invest"},{"issue":"2","key":"786_CR73","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/00005072-197404000-00001","volume":"33","author":"GE Gibson","year":"1974","unstructured":"Gibson GE, Zimber A, Krook L, Richardson EP Jr, Visek WJ. Brain histology and behavior of mice injected with urease. J Neuropathol Exp Neurol. 1974;33(2):201\u201311.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"786_CR74","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/00005072-198507000-00004","volume":"44","author":"JB Gregorios","year":"1985","unstructured":"Gregorios JB, Mozes LW, Norenberg MD. Morphologic effects of ammonia on primary astrocyte cultures. II. Electron microscopic studies. J Neuropathol Exp Neurol. 1985;44(4):404\u201314.","journal-title":"J Neuropathol Exp Neurol"},{"key":"786_CR75","doi-asserted-by":"crossref","unstructured":"Shulyatnikova TV, Tumanskyi VO. Ammonia level and alzheimer type 2 astrocytes in the brain of deceased patients with liver cirrhosis of the varying degree. 2023.","DOI":"10.14739\/2310-1237.2023.1.276453"},{"issue":"3","key":"786_CR76","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jhep.2022.06.001","volume":"77","author":"S Montagnese","year":"2022","unstructured":"Montagnese S, Rautou PE, Romero-G\u00f3mez M, Larsen FS, Shawcross DL, Thabut D, et al. EASL clinical practice guidelines on the management of hepatic encephalopathy. J Hepatol. 2022;77(3):807\u201324.","journal-title":"J Hepatol"},{"key":"786_CR77","doi-asserted-by":"crossref","unstructured":"El-Mansoury B, Smimih K, Hamdan YA, El Khiat A, Elouali S, El Fatimi H, et al. The interplay between environmental pollutants, gut microbiota, and infections: current concepts and therapies. Ecol Evol Perspect Infect Morb. 2023;173\u2013207.","DOI":"10.4018\/978-1-7998-9414-8.ch008"},{"key":"786_CR78","doi-asserted-by":"publisher","unstructured":"Fatimi H, El, El-Mansoury B, Tinakoua A, Ndayambaje M, Zaid Y, Khalki H, et al. Gut microbiota in anxiety and depression: mechanisms, drug interactions, and therapeutic implications. Pharmacol Reports [Internet]. 2025; Available from: https:\/\/doi.org\/10.1007\/s43440-025-00759-w","DOI":"10.1007\/s43440-025-00759-w"},{"issue":"1","key":"786_CR79","doi-asserted-by":"publisher","first-page":"26800","DOI":"10.1038\/srep26800","volume":"6","author":"V Ahluwalia","year":"2016","unstructured":"Ahluwalia V, Betrapally NS, Hylemon PB, White MB, Gillevet PM, Unser AB, et al. Impaired gut-liver-brain axis in patients with cirrhosis. Sci Rep. 2016;6(1):26800.","journal-title":"Sci Rep"},{"issue":"40","key":"786_CR80","doi-asserted-by":"publisher","first-page":"6141","DOI":"10.3748\/wjg.v26.i40.6141","volume":"26","author":"JH Ding","year":"2020","unstructured":"Ding JH, Jin Z, Yang XX, Lou J, Shan WX, Hu YX, et al. Role of gut microbiota via the gut-liver-brain axis in digestive diseases. World J Gastroenterol. 2020;26(40):6141.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"786_CR81","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/hep.30827","volume":"71","author":"R Liu","year":"2020","unstructured":"Liu R, Kang JD, Sartor RB, Sikaroodi M, Fagan A, Gavis EA, et al. Neuroinflammation in murine cirrhosis is dependent on the gut Microbiome and is attenuated by fecal transplant. Hepatology. 2020;71(2):611\u201326.","journal-title":"Hepatology"},{"issue":"7","key":"786_CR82","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/jgh.12160","volume":"28","author":"L Jain","year":"2013","unstructured":"Jain L, Sharma BC, Srivastava S, Puri SK, Sharma P, Sarin S. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy. J Gastroenterol Hepatol. 2013;28(7):1187\u201393.","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"786_CR83","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1038\/ajg.2013.221","volume":"108","author":"Z Zhang","year":"2013","unstructured":"Zhang Z, Zhai H, Geng J, Yu R, Ren H, Fan H, et al. Large-Scale survey of gut microbiota associated with MHE via 16S rRNA-Based pyrosequencing. Am J Gastroenterol. 2013;108(10):1601\u201311.","journal-title":"Am J Gastroenterol"},{"key":"786_CR84","doi-asserted-by":"crossref","unstructured":"Shah A, Shanahan E, Macdonald GA, Fletcher L, Ghasemi P, Morrison M, et al. Systematic review and meta-analysis: prevalence of small intestinal bacterial overgrowth in chronic liver disease. In: seminars in liver disease. Thieme Medical Publishers. 2017:388\u2013400.","DOI":"10.1055\/s-0037-1608832"},{"issue":"10","key":"786_CR85","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/1751-2980.12816","volume":"20","author":"JY Wang","year":"2019","unstructured":"Wang JY, Bajaj JS, Wang J, Bin, Shang J, Zhou XM, Guo XL, et al. Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial. J Dig Dis. 2019;20(10):547\u201356.","journal-title":"J Dig Dis"},{"issue":"6","key":"786_CR86","first-page":"G675","volume":"303","author":"JS Bajaj","year":"2012","unstructured":"Bajaj JS, Hylemon PB, Ridlon JM, Heuman DM, Daita K, White MB, et al. Colonic mucosal Microbiome differs from stool Microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am J Physiol Liver Physiol. 2012;303(6):G675\u201385.","journal-title":"Am J Physiol Liver Physiol"},{"issue":"3","key":"786_CR87","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/hep.21533","volume":"45","author":"S Prasad","year":"2007","unstructured":"Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology. 2007;45(3):549\u201359.","journal-title":"Hepatology"},{"key":"786_CR88","doi-asserted-by":"crossref","unstructured":"Als-Nielsen B, Gluud LL, Gluud C. Nonabsorbable disaccharides for hepatic encephalopathy. Cochrane Database Syst Rev. 2004;(2).","DOI":"10.1002\/14651858.CD003044.pub2"},{"key":"786_CR89","doi-asserted-by":"crossref","unstructured":"Gluud LL, Vilstrup H, Morgan MY. Non-absorbable disaccharides versus placebo\/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database Syst Rev. 2016;(5).","DOI":"10.1002\/14651858.CD003044.pub4"},{"issue":"9","key":"786_CR90","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/ajg.2013.219","volume":"108","author":"BC Sharma","year":"2013","unstructured":"Sharma BC, Sharma P, Lunia MK, Srivastava S, Goyal R, Sarin SK. A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. Off J Am Coll Gastroenterol ACG. 2013;108(9):1458\u201363.","journal-title":"Off J Am Coll Gastroenterol ACG"},{"key":"786_CR91","doi-asserted-by":"publisher","unstructured":"McGuire B, Al Sibae M. Current trends in the treatment of hepatic encephalopathy. Ther Clin Risk Manag [Internet]. 2009;617. Available from: https:\/\/doi.org\/10.2147\/tcrm.s4443","DOI":"10.2147\/tcrm.s4443"},{"key":"786_CR92","doi-asserted-by":"crossref","unstructured":"Tejpal S, Sharma SK, Sharma A, Sharma S, Road GT. A comprehensive review on hepatic encephalopathy: pathophysiology, symptoms, epidemiology, classification, diagnosis and treatment. J Res Appl Sci Biotechnol. 2024;(3):170\u201380.","DOI":"10.55544\/jrasb.3.3.27"},{"issue":"3","key":"786_CR93","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3349\/ymj.2005.46.3.399","volume":"46","author":"YH Paik","year":"2005","unstructured":"Paik YH, Lee KS, Han KH, Song KH, Kim MH, Moon BS, et al. Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: a prospective randomized study. Yonsei Med J. 2005;46(3):399.","journal-title":"Yonsei Med J"},{"issue":"1","key":"786_CR94","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0168-8278(02)00350-1","volume":"38","author":"A Mas","year":"2003","unstructured":"Mas A, Rod\u00e9s J, Sunyer L, Rodrigo L, Planas R, Vargas V, et al. Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial. J Hepatol. 2003;38(1):51\u20138.","journal-title":"J Hepatol"},{"issue":"12","key":"786_CR95","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","volume":"362","author":"NM Bass","year":"2010","unstructured":"Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010;362(12):1071\u201381.","journal-title":"N Engl J Med"},{"key":"786_CR96","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/apt.13435","volume":"43","author":"JS Bajaj","year":"2016","unstructured":"Bajaj JS. Potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis. Aliment Pharmacol Ther. 2016;43:11\u201326.","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"786_CR97","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1097\/MEG.0b013e328302f470","volume":"20","author":"Q Jiang","year":"2008","unstructured":"Jiang Q, Jiang XH, Zheng MH, Jiang LM, Chen YP, Wang L. Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis. Eur J Gastroenterol Hepatol. 2008;20(11):1064\u201370.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"786_CR98","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3350\/cmh.2019.0015","volume":"25","author":"A Jindal","year":"2019","unstructured":"Jindal A, Jagdish RK. Sarcopenia: ammonia metabolism and hepatic encephalopathy. Clin Mol Hepatol. 2019;25(3):270.","journal-title":"Clin Mol Hepatol"},{"issue":"8","key":"786_CR99","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506\u201314.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"786_CR100","doi-asserted-by":"crossref","unstructured":"El-Mansoury B, Smimih K, El Khiat A, El Fatimi H, Aimrane A, El Baz S, et al. Potential role of probiotics and fecal microbiota transplantation in the treatment of Parkinson\u2019s disease. In: experimental and clinical evidence of the neuropathology of Parkinson\u2019s disease. IGI Global. 2023:296\u2013317.","DOI":"10.4018\/978-1-6684-5156-4.ch017"},{"issue":"9","key":"786_CR101","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3390\/nu9091021","volume":"9","author":"P Markowiak","year":"2017","unstructured":"Markowiak P, \u015ali\u017cewska K. Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients. 2017;9(9):1021.","journal-title":"Nutrients"},{"issue":"6","key":"786_CR102","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1365-2036.2010.04574.x","volume":"33","author":"S Shukla","year":"2011","unstructured":"Shukla S, Shukla A, Mehboob S, Guha S. Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment Pharmacol Ther. 2011;33(6):662\u201371.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"786_CR103","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.cgh.2013.11.006","volume":"12","author":"MK Lunia","year":"2014","unstructured":"Lunia MK, Sharma BC, Sharma P, Sachdeva S, Srivastava S. Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial. Clin Gastroenterol Hepatol. 2014;12(6):1003\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"786_CR104","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/ajg.2012.113","volume":"107","author":"A Agrawal","year":"2012","unstructured":"Agrawal A, Sharma BC, Sharma P, Sarin SK. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy. Off J Am Coll Gastroenterol ACG. 2012;107(7):1043\u201350.","journal-title":"Off J Am Coll Gastroenterol ACG"},{"issue":"6","key":"786_CR105","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/MEG.0b013e3282f3e6f5","volume":"20","author":"P Sharma","year":"2008","unstructured":"Sharma P, Sharma BC, Puri V, Sarin SK. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol. 2008;20(6):506\u201311.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"786_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-018-0494-4","volume":"6","author":"JA Krumbeck","year":"2018","unstructured":"Krumbeck JA, Rasmussen HE, Hutkins RW, Clarke J, Shawron K, Keshavarzian A, et al. Probiotic bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics. Microbiome. 2018;6:1\u201316.","journal-title":"Microbiome"},{"key":"786_CR107","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1007\/s10620-006-9687-y","volume":"52","author":"M Malaguarnera","year":"2007","unstructured":"Malaguarnera M, Greco F, Barone G, Gargante MP, Malaguarnera M, Toscano MA. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig Dis Sci. 2007;52:3259\u201365.","journal-title":"Dig Dis Sci"},{"issue":"5","key":"786_CR108","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/hep.20194","volume":"39","author":"Q Liu","year":"2004","unstructured":"Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology. 2004;39(5):1441\u20139.","journal-title":"Hepatology"},{"key":"786_CR109","doi-asserted-by":"publisher","unstructured":"Bloom PP, Tapper EB, Young VB, Lok AS. Microbiome therapeutics for hepatic encephalopathy. J Hepatol [Internet]. 2021;75(6):1452\u201364. Available from: https:\/\/doi.org\/10.1016\/j.jhep.2021.08.004","DOI":"10.1016\/j.jhep.2021.08.004"},{"issue":"8","key":"786_CR110","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.cgh.2022.04.034","volume":"20","author":"MA Fallahzadeh","year":"2022","unstructured":"Fallahzadeh MA, Rahimi RS. Hepatic encephalopathy: current and emerging treatment modalities. Clin Gastroenterol Hepatol. 2022;20(8):S9\u201319.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"786_CR111","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1053\/j.gastro.2019.01.033","volume":"156","author":"JS Bajaj","year":"2019","unstructured":"Bajaj JS, Fagan A, Gavis EA, Kassam Z, Sikaroodi M, Gillevet PM. Long-term outcomes after fecal microbiota transplant in cirrhosis. Gastroenterology. 2019;156(6):1921.","journal-title":"Gastroenterology"},{"issue":"6","key":"786_CR112","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/hep.29306","volume":"66","author":"JS Bajaj","year":"2017","unstructured":"Bajaj JS, Kassam Z, Fagan A, Gavis EA, Liu E, Cox IJ, et al. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial. Hepatology. 2017;66(6):1727\u201338.","journal-title":"Hepatology"},{"issue":"6","key":"786_CR113","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/hep.510250609","volume":"25","author":"G Kircheis","year":"1997","unstructured":"Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Gortelmeyer R, et al. Therapeutic efficacy of L-ornithine\u2010L\u2010aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo\u2010controlled, double\u2010blind study. Hepatology. 1997;25(6):1351\u201360.","journal-title":"Hepatology"},{"key":"786_CR114","doi-asserted-by":"crossref","unstructured":"He Q, Mao C, Chen Z, Zeng Y, Deng Y, Hu R. Efficacy of L-ornithine L-aspartate for minimal hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials. Arab J Gastroenterol. 2024.","DOI":"10.1016\/j.ajg.2024.01.006"},{"issue":"2","key":"786_CR115","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/hep.29410","volume":"67","author":"SS Sidhu","year":"2018","unstructured":"Sidhu SS, Sharma BC, Goyal O, Kishore H, Kaur N. L-ornithine L\u2010aspartate in bouts of overt hepatic encephalopathy. Hepatology. 2018;67(2):700\u201310.","journal-title":"Hepatology"},{"issue":"5","key":"786_CR116","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/S0168-8278(98)80237-7","volume":"28","author":"S Stauch","year":"1998","unstructured":"Stauch S, Kircheis G, Adler G, Beckh K, Ditschuneit H, G\u00f6rtelmeyer R, et al. Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study. J Hepatol. 1998;28(5):856\u201364.","journal-title":"J Hepatol"},{"issue":"7","key":"786_CR117","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/apt.13122","volume":"41","author":"G Zhu","year":"2015","unstructured":"Zhu G, Shi K, Huang S, Wang L, Lin Y, Huang G, et al. Systematic review with network meta-analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy. Aliment Pharmacol Ther. 2015;41(7):624\u201335.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"786_CR118","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S1665-2681(19)31989-1","volume":"5","author":"JL Poo","year":"2006","unstructured":"Poo JL, G\u00f3ngora J, S\u00e1nchez-\u00c1vila F, Aguilar-Castillo S, Garc\u00eda-Ramos G, Fern\u00e1ndez-Zertuche M, et al. Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study. Ann Hepatol. 2006;5(4):281\u20138.","journal-title":"Ann Hepatol"},{"issue":"3","key":"786_CR119","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000073347","volume":"21","author":"M Malaguarnera","year":"2003","unstructured":"Malaguarnera M, Pistone G, Astuto M, Dell\u2019Arte S, Finocchiaro G, Lo Giudice E, et al. L-Carnitine in the treatment of mild or moderate hepatic encephalopathy. Dig Dis. 2003;21(3):271\u20135.","journal-title":"Dig Dis"},{"issue":"45","key":"786_CR120","doi-asserted-by":"publisher","first-page":"7197","DOI":"10.3748\/wjg.v11.i45.7197","volume":"11","author":"M Malaguarnera","year":"2005","unstructured":"Malaguarnera M, Pistone G, Elvira R, Leotta C, Scarpello L, Liborio R. Effects of L-carnitine in patients with hepatic encephalopathy. World J Gastroenterol. 2005;11(45):7197.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"786_CR121","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3109\/00365521.2011.565067","volume":"46","author":"M Malaguarnera","year":"2011","unstructured":"Malaguarnera M, Bella R, Vacante M, Giordano M, Malaguarnera G, Gargante MP, et al. Acetyl-l-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy. Scand J Gastroenterol. 2011;46(6):750\u20139.","journal-title":"Scand J Gastroenterol"},{"issue":"12","key":"786_CR122","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1111\/jgh.14765","volume":"34","author":"A Abbasnezhad","year":"2019","unstructured":"Abbasnezhad A, Choghakhori R, Kashkooli S, Alipour M, Asbaghi O, Mohammadi R. Effect of L-carnitine on liver enzymes and biochemical factors in hepatic encephalopathy: A systematic review and meta\u2010analysis. J Gastroenterol Hepatol. 2019;34(12):2062\u201370.","journal-title":"J Gastroenterol Hepatol"},{"key":"786_CR123","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11011-011-9260-z","volume":"26","author":"M Malaguarnera","year":"2011","unstructured":"Malaguarnera M, Vacante M, Motta M, Giordano M, Malaguarnera G, Bella R, et al. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial. Metab Brain Dis. 2011;26:281\u20139.","journal-title":"Metab Brain Dis"},{"key":"786_CR124","doi-asserted-by":"crossref","unstructured":"Mart\u00ed-Carvajal AJ, Gluud C, Arevalo\u2010Rodriguez I, Mart\u00ed\u2010Amarista CE. Acetyl\u2010L\u2010carnitine for patients with hepatic encephalopathy. Cochrane Database Syst Rev. 2019;(1).","DOI":"10.1002\/14651858.CD011451.pub2"},{"issue":"10","key":"786_CR125","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/MCG.0b013e318299c789","volume":"47","author":"M Ventura-Cots","year":"2013","unstructured":"Ventura-Cots M, Arranz JA, Simon-Talero M, Torrens M, Blanco A, Riudor E, et al. Safety of ornithine phenylacetate in cirrhotic decompensated patients: an open-label, dose-escalating, single-cohort study. J Clin Gastroenterol. 2013;47(10):881\u20137.","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"786_CR126","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/hep.22917","volume":"50","author":"LM Ytreb\u00f8","year":"2009","unstructured":"Ytreb\u00f8 LM, Kristiansen RG, M\u00e6hre H, Fuskev\u00e5g OM, Kalstad T, Revhaug A, et al. L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure. Hepatology. 2009;50(1):165\u201374.","journal-title":"Hepatology"},{"issue":"2","key":"786_CR127","first-page":"60","volume":"10","author":"RIM Almoselhy","year":"2024","unstructured":"Almoselhy RIM. Nutraceuticals rich in zinc and branched chain amino acids for improving quality of life in patients with chronic liver disease, hepatic encephalopathy, and geriatrics. Ann Geriatr Educ Med Sci. 2024;10(2):60\u20132.","journal-title":"Ann Geriatr Educ Med Sci"},{"issue":"19","key":"786_CR128","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.3748\/wjg.v29.i19.2905","volume":"29","author":"G Marrone","year":"2023","unstructured":"Marrone G, Serra A, Miele L, Biolato M, Liguori A, Grieco A, et al. Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: evidence and uncertainties. World J Gastroenterol. 2023;29(19):2905\u201315.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"786_CR129","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.3945\/jn.113.174375","volume":"143","author":"LL Gluud","year":"2013","unstructured":"Gluud LL, Dam G, Borre M, Les I, Cordoba J, Marchesini G, et al. Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials. J Nutr. 2013;143(8):1263\u20138.","journal-title":"J Nutr"},{"issue":"7","key":"786_CR130","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/S0016-5085(03)00323-8","volume":"124","author":"G Marchesini","year":"2003","unstructured":"Marchesini G, Bianchi G, Merli M, Amodio P, Panella C, Loguercio C, et al. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology. 2003;124(7):1792\u2013801.","journal-title":"Gastroenterology"},{"issue":"7","key":"786_CR131","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S1542-3565(05)00017-0","volume":"3","author":"Y Muto","year":"2005","unstructured":"Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol. 2005;3(7):705\u201313.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"786_CR132","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/ajg.2011.9","volume":"106","author":"I Les","year":"2011","unstructured":"Les I, Doval E, Garc\u00eda-Mart\u00ednez R, Planas M, C\u00e1rdenas G, G\u00f3mez P, et al. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study. Off J Am Coll Gastroenterol ACG. 2011;106(6):1081\u20138.","journal-title":"Off J Am Coll Gastroenterol ACG"},{"issue":"6","key":"786_CR133","first-page":"56","volume":"31","author":"VT Ivashkin","year":"2022","unstructured":"Ivashkin VT, Maevskaya MV, Zharkova MS, Zhigalova SB, Kitsenko EA, Manukyan GV, et al. Clinical recommendations of the Russian scientific liver society and Russian gastroenterological association on diagnosis and treatment of liver fibrosis, cirrhosis and their complications. Russ J Gastroenterol Hepatol Coloproctology. 2022;31(6):56\u2013102.","journal-title":"Russ J Gastroenterol Hepatol Coloproctology"},{"issue":"1","key":"786_CR134","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jceh.2020.09.003","volume":"11","author":"P Puri","year":"2021","unstructured":"Puri P, Dhiman RK, Taneja S, Tandon P, Merli M, Anand AC, et al. Nutrition in chronic liver disease: consensus statement of the Indian National association for study of the liver. J Clin Exp Hepatol. 2021;11(1):97\u2013143.","journal-title":"J Clin Exp Hepatol"},{"issue":"2","key":"786_CR135","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.clnu.2018.12.022","volume":"38","author":"M Plauth","year":"2019","unstructured":"Plauth M, Bernal W, Dasarathy S, Merli M, Plank LD, Sch\u00fctz T, et al. ESPEN guideline on clinical nutrition in liver disease. Clin Nutr. 2019;38(2):485\u2013521.","journal-title":"Clin Nutr"},{"key":"786_CR136","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/j.jceh.2017.01.057","volume":"7","author":"S Tripon","year":"2017","unstructured":"Tripon S, Lodey M, Guiller E, Mallet M. Sodium phenylbutyrate administration to avoid neurological worsening in cirrhotic patients with hepatic encephalopathy admitted in ICU. J Clin Exp Hepatol. 2017;7:S43\u20134.","journal-title":"J Clin Exp Hepatol"},{"issue":"2","key":"786_CR137","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/fcp.12340","volume":"32","author":"N Weiss","year":"2018","unstructured":"Weiss N, Tripon S, Lodey M, Guiller E, Junot H, Monneret D, et al. Treating hepatic encephalopathy in cirrhotic patients admitted to ICU with sodium phenylbutyrate: a preliminary study. Fundam Clin Pharmacol. 2018;32(2):209\u201315.","journal-title":"Fundam Clin Pharmacol"},{"issue":"4","key":"786_CR138","first-page":"219","volume":"9","author":"ML Misel","year":"2013","unstructured":"Misel ML, Gish RG, Patton H, Mendler M. Sodium benzoate for treatment of hepatic encephalopathy. Gastroenterol Hepatol. 2013;9(4):219\u201327.","journal-title":"Gastroenterol Hepatol"},{"issue":"6","key":"786_CR139","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/jnr.21947","volume":"87","author":"O Cauli","year":"2009","unstructured":"Cauli O, Rodrigo R, Piedrafita B, Llansola M, Mansouri MT, Felipo V. Neuroinflammation contributes to hypokinesia in rats with hepatic encephalopathy: ibuprofen restores its motor activity. J Neurosci Res. 2009;87(6):1369\u201374.","journal-title":"J Neurosci Res"},{"issue":"2","key":"786_CR140","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/hep.21734","volume":"46","author":"O Cauli","year":"2007","unstructured":"Cauli O, Rodrigo R, Piedrafita B, Boix J, Felipo V. Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts. Hepatology. 2007;46(2):514\u20139.","journal-title":"Hepatology"},{"key":"786_CR141","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.brainresbull.2019.04.015","volume":"149","author":"F Mohammadian","year":"2019","unstructured":"Mohammadian F, Firouzjaei MA, Haghani M, Shabani M, Moosavi SMS, Mohammadi F. Inhibition of inflammation is not enough for recovery of cognitive impairment in hepatic encephalopathy: effects of Minocycline and ibuprofen. Brain Res Bull. 2019;149:96\u2013105.","journal-title":"Brain Res Bull"},{"issue":"11","key":"786_CR142","doi-asserted-by":"publisher","first-page":"e49670","DOI":"10.1371\/journal.pone.0049670","volume":"7","author":"A Chastre","year":"2012","unstructured":"Chastre A, B\u00e9langer M, Beauchesne E, Nguyen BN, Desjardins P, Butterworth RF. Inflammatory cascades driven by tumor necrosis factor-alpha play a major role in the progression of acute liver failure and its neurological complications. PLoS ONE. 2012;7(11):e49670.","journal-title":"PLoS ONE"},{"key":"786_CR143","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3389\/fnmol.2016.00106","volume":"9","author":"S Dadsetan","year":"2016","unstructured":"Dadsetan S, Balzano T, Forteza J, Cabrera-Pastor A, Taoro-Gonzalez L, Hernandez-Rabaza V, et al. Reducing peripheral inflammation with Infliximab reduces neuroinflammation and improves cognition in rats with hepatic encephalopathy. Front Mol Neurosci. 2016;9:106.","journal-title":"Front Mol Neurosci"},{"key":"786_CR144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-016-0710-8","volume":"13","author":"S Dadsetan","year":"2016","unstructured":"Dadsetan S, Balzano T, Forteza J, Agusti A, Cabrera-Pastor A, Taoro-Gonzalez L, et al. Infliximab reduces peripheral inflammation, neuroinflammation, and extracellular GABA in the cerebellum and improves learning and motor coordination in rats with hepatic encephalopathy. J Neuroinflammation. 2016;13:1\u201314.","journal-title":"J Neuroinflammation"},{"issue":"6","key":"786_CR145","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1053\/j.gastro.2008.08.057","volume":"135","author":"NC Boetticher","year":"2008","unstructured":"Boetticher NC, Peine CJ, Kwo P, Abrams GA, Patel T, Aqel B, et al. A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology. 2008;135(6):1953\u201360.","journal-title":"Gastroenterology"},{"issue":"3","key":"786_CR146","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jhep.2008.10.024","volume":"50","author":"P Sharma","year":"2009","unstructured":"Sharma P, Kumar A, Sharma BC, Sarin SK. Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial. J Hepatol. 2009;50(3):584\u201391.","journal-title":"J Hepatol"},{"issue":"2","key":"786_CR147","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1471-4159.2009.05981.x","volume":"109","author":"W Jiang","year":"2009","unstructured":"Jiang W, Desjardins P, Butterworth RF. Cerebral inflammation contributes to encephalopathy and brain edema in acute liver failure: protective effect of Minocycline. J Neurochem. 2009;109(2):485\u201393.","journal-title":"J Neurochem"},{"issue":"1","key":"786_CR148","first-page":"254683","volume":"2014","author":"M Gamal","year":"2014","unstructured":"Gamal M, Abdel Wahab Z, Eshra M, Rashed L, Sharawy N. Comparative neuroprotective effects of dexamethasone and Minocycline during hepatic encephalopathy. Neurol Res Int. 2014;2014(1):254683.","journal-title":"Neurol Res Int"},{"issue":"1","key":"786_CR149","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-015-0420-7","volume":"12","author":"V Hernandez-Rabaza","year":"2015","unstructured":"Hernandez-Rabaza V, Agusti A, Cabrera-Pastor A, Fustero S, Delgado O, Taoro-Gonzalez L, et al. Sildenafil reduces neuroinflammation and restores Spatial learning in rats with hepatic encephalopathy: underlying mechanisms. J Neuroinflammation. 2015;12(1):1\u201312.","journal-title":"J Neuroinflammation"},{"issue":"5","key":"786_CR150","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/cns.12688","volume":"23","author":"A Agusti","year":"2017","unstructured":"Agusti A, Hern\u00e1ndez-Rabaza V, Balzano T, Taoro\u2010Gonzalez L, Iba\u00f1ez\u2010Grau A, Cabrera\u2010Pastor A, et al. Sildenafil reduces neuroinflammation in cerebellum, restores GABA ergic tone, and improves motor in\u2010coordination in rats with hepatic encephalopathy. CNS Neurosci Ther. 2017;23(5):386\u201394.","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"786_CR151","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/hep.20565","volume":"41","author":"S Erceg","year":"2005","unstructured":"Erceg S, Monfort P, Hern\u00e1ndez-Viadel M, Rodrigo R, Montoliu C, Felipo V. Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts. Hepatology. 2005;41(2):299\u2013306.","journal-title":"Hepatology"},{"issue":"1","key":"786_CR152","doi-asserted-by":"publisher","first-page":"50","DOI":"10.21608\/bvmj.2024.264516.1774","volume":"46","author":"R Said","year":"2024","unstructured":"Said R, Mahmoud O, Mohammed A, Abd El Maksoud H. Biochemical role of Tadalafil in experimental brain impairment activities in mice. Benha Vet Med J. 2024;46(1):50\u20133.","journal-title":"Benha Vet Med J"},{"key":"786_CR153","doi-asserted-by":"publisher","first-page":"114673","DOI":"10.1016\/j.taap.2019.114673","volume":"379","author":"MER Fran\u00e7a","year":"2019","unstructured":"Fran\u00e7a MER, Ramos RKLG, Oliveira WH, Duarte-Silva E, Ara\u00fajo SMR, Los DB, et al. Tadalafil restores long-term memory and synaptic plasticity in mice with hepatic encephalopathy. Toxicol Appl Pharmacol. 2019;379:114673.","journal-title":"Toxicol Appl Pharmacol"},{"key":"786_CR154","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11011-007-9067-0","volume":"22","author":"M Llansola","year":"2007","unstructured":"Llansola M, Rodrigo R, Monfort P, Montoliu C, Kosenko E, Cauli O, et al. NMDA receptors in hyperammonemia and hepatic encephalopathy. Metab Brain Dis. 2007;22:321\u201335.","journal-title":"Metab Brain Dis"},{"issue":"6","key":"786_CR155","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1046\/j.1471-4159.1994.63062172.x","volume":"63","author":"E Kosenko","year":"1994","unstructured":"Kosenko E, Kaminsky Y, Grau E, Mi\u00f1ana M, Marcaida G, Grisol\u00eda S, et al. Brain ATP depletion induced by acute ammonia intoxication in rats is mediated by activation of the NMDA receptor and Na+, K+-ATPase. J Neurochem. 1994;63(6):2172\u20138.","journal-title":"J Neurochem"},{"key":"786_CR156","doi-asserted-by":"publisher","first-page":"1358323","DOI":"10.3389\/fphar.2024.1358323","volume":"15","author":"M Llansola","year":"2024","unstructured":"Llansola M, Arenas YM, Sancho-Alonso M, Mincheva G, Palomares-Rodriguez A, Doverskog M, et al. Neuroinflammation alters GABAergic neurotransmission in hyperammonemia and hepatic encephalopathy, leading to motor incoordination. Mechanisms and therapeutic implications. Front Pharmacol. 2024;15:1358323.","journal-title":"Front Pharmacol"},{"key":"786_CR157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-016-0549-z","volume":"13","author":"V Hernandez-Rabaza","year":"2016","unstructured":"Hernandez-Rabaza V, Cabrera-Pastor A, Taoro-Gonzalez L, Gonzalez-Usano A, Agusti A, Balzano T, et al. Neuroinflammation increases GABAergic tone and impairs cognitive and motor function in hyperammonemia by increasing GAT-3 membrane expression. Reversal by Sulforaphane by promoting M2 polarization of microglia. J Neuroinflammation. 2016;13:1\u201313.","journal-title":"J Neuroinflammation"},{"key":"786_CR158","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1023\/B:MEBR.0000043979.58915.41","volume":"19","author":"S Ahboucha","year":"2004","unstructured":"Ahboucha S, Butterworth RF. Pathophysiology of hepatic encephalopathy: a new look at GABA from the molecular standpoint. Metab Brain Dis. 2004;19:331\u201343.","journal-title":"Metab Brain Dis"},{"issue":"2","key":"786_CR159","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1021\/cn400168y","volume":"5","author":"A Gonzalez-Usano","year":"2014","unstructured":"Gonzalez-Usano A, Cauli O, Agusti A, Felipo V. Pregnenolone sulfate restores the glutamate-nitric-oxide-cGMP pathway and extracellular GABA in cerebellum and learning and motor coordination in hyperammonemic rats. ACS Chem Neurosci. 2014;5(2):100\u20135.","journal-title":"ACS Chem Neurosci"},{"issue":"5","key":"786_CR160","first-page":"G400","volume":"309","author":"M Johansson","year":"2015","unstructured":"Johansson M, Agusti A, Llansola M, Montoliu C, Str\u00f6mberg J, Malinina E, et al. GR3027 antagonizes GABA A receptor-potentiating neurosteroids and restores Spatial learning and motor coordination in rats with chronic hyperammonemia and hepatic encephalopathy. Am J Physiol Liver Physiol. 2015;309(5):G400\u20139.","journal-title":"Am J Physiol Liver Physiol"},{"issue":"2","key":"786_CR161","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/liv.15782","volume":"44","author":"YM Arenas","year":"2024","unstructured":"Arenas YM, Izquierdo-Altarejos P, Martinez\u2010Garc\u00eda M, Gim\u00e9nez\u2010Garz\u00f3 C, Mincheva G, Doverskog M, et al. Golexanolone improves fatigue, motor incoordination and gait and memory in rats with bile duct ligation. Liver Int. 2024;44(2):433\u201345.","journal-title":"Liver Int"},{"issue":"1","key":"786_CR162","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jhep.2021.03.012","volume":"75","author":"S Montagnese","year":"2021","unstructured":"Montagnese S, Lauridsen M, Vilstrup H, Zarantonello L, Lakner G, Fitilev S, et al. A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with Covert hepatic encephalopathy. J Hepatol. 2021;75(1):98\u2013107.","journal-title":"J Hepatol"},{"key":"786_CR163","doi-asserted-by":"crossref","unstructured":"Goh ET, Andersen ML, Morgan MY, Gluud LL. Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy. Cochrane Database Syst Rev. 2017;(8).","DOI":"10.1002\/14651858.CD002798.pub4"},{"issue":"2","key":"786_CR164","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cld.2024.02.002","volume":"28","author":"AP Buckholz","year":"2024","unstructured":"Buckholz AP, Brown RS. Future therapies of hepatic encephalopathy. Clin Liver Dis. 2024;28(2):331\u201344.","journal-title":"Clin Liver Dis"},{"issue":"4","key":"786_CR165","first-page":"308","volume":"116","author":"HK Chela","year":"2019","unstructured":"Chela HK, Basra N, Naqvi SH. Hepatic encephalopathy in the hospitalized patient: a review for hospitalists. Mo Med. 2019;116(4):308.","journal-title":"Mo Med"},{"issue":"2","key":"786_CR166","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jhep.2012.03.017","volume":"57","author":"G Germani","year":"2012","unstructured":"Germani G, Theocharidou E, Adam R, Karam V, Wendon J, O\u2019Grady J, et al. Liver transplantation for acute liver failure in europe: outcomes over 20 years from the ELTR database. J Hepatol. 2012;57(2):288\u201396.","journal-title":"J Hepatol"},{"issue":"4","key":"786_CR167","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3748\/wjg.v22.i4.1523","volume":"22","author":"M Mendizabal","year":"2016","unstructured":"Mendizabal M, Silva MO. Liver transplantation in acute liver failure: A challenging scenario. World J Gastroenterol. 2016;22(4):1523.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"786_CR168","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jhep.2024.06.039","volume":"82","author":"F Artru","year":"2025","unstructured":"Artru F, Sacleux SC, Ursic-Bedoya J, Wandji LCN, Lutu A, L\u2019hermite S, et al. Long-term outcome following liver transplantation of patients with ACLF grade 3. J Hepatol. 2025;82(1):62\u201371.","journal-title":"J Hepatol"},{"key":"786_CR169","doi-asserted-by":"publisher","unstructured":"Chi A, Chan Y, Tat S. Criteria for liver transplantation in ACLF and outcome. Hepatol Int [Internet]. 2015;355\u20139. Available from: https:\/\/doi.org\/10.1007\/s12072-014-9585-x","DOI":"10.1007\/s12072-014-9585-x"},{"issue":"7","key":"786_CR170","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1097\/TP.0000000000003550","volume":"105","author":"CJ Karvellas","year":"2021","unstructured":"Karvellas CJ, Francoz C, Weiss E. Liver transplantation in Acute-on-chronic liver failure. Transplantation. 2021;105(7):1471\u201381.","journal-title":"Transplantation"},{"issue":"7","key":"786_CR171","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1053\/j.gastro.2010.02.015","volume":"138","author":"JS Bajaj","year":"2010","unstructured":"Bajaj JS, Schubert CM, Heuman DM, Wade JB, Gibson DP, Topaz A, et al. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology. 2010;138(7):2332\u201340.","journal-title":"Gastroenterology"},{"issue":"9","key":"786_CR172","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1038\/ctg.2015.38","volume":"6","author":"R Rai","year":"2015","unstructured":"Rai R, Ahuja CK, Agrawal S, Kalra N, Duseja A, Khandelwal N, et al. Reversal of low-grade cerebral edema after lactulose\/rifaximin therapy in patients with cirrhosis and minimal hepatic encephalopathy. Clin Transl Gastroenterol. 2015;6(9):e111.","journal-title":"Clin Transl Gastroenterol"},{"issue":"2","key":"786_CR173","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cgh.2010.10.002","volume":"9","author":"O Riggio","year":"2011","unstructured":"Riggio O, Ridola L, Pasquale C, Nardelli S, Pentassuglio I, Moscucci F, et al. Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy. Clin Gastroenterol Hepatol. 2011;9(2):181\u20133.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"786_CR174","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184(10):2537\u201364.","journal-title":"Cell"},{"issue":"02","key":"786_CR175","doi-asserted-by":"publisher","first-page":"182","DOI":"10.4103\/ijri.IJRI_96_19","volume":"29","author":"A Mukund","year":"2019","unstructured":"Mukund A, Bhardwaj K, Mohan C. Basic interventional procedures: practice essentials. Indian J Radiol Imaging. 2019;29(02):182\u20139.","journal-title":"Indian J Radiol Imaging"},{"issue":"03","key":"786_CR176","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4103\/0971-3026.41840","volume":"18","author":"SJ Punamiya","year":"2008","unstructured":"Punamiya SJ. Interventional radiology in the management of portal hypertension. Indian J Radiol Imaging. 2008;18(03):249\u201355.","journal-title":"Indian J Radiol Imaging"},{"issue":"1","key":"786_CR177","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/jcm13010014","volume":"13","author":"KH Friis","year":"2023","unstructured":"Friis KH, Thomsen KL, Laleman W, Montagnese S, Vilstrup H, Lauridsen MM. Post-Transjugular intrahepatic portosystemic shunt (TIPS) hepatic encephalopathy\u2014a review of the past decade\u2019s literature focusing on incidence, risk factors, and prophylaxis. J Clin Med. 2023;13(1):14.","journal-title":"J Clin Med"},{"key":"786_CR178","doi-asserted-by":"crossref","unstructured":"Copelan A, Kapoor B, Sands M. Transjugular intrahepatic portosystemic shunt: indications, contraindications, and patient work-up. In: seminars in interventional radiology. Thieme Medical. 2014:235\u201342.","DOI":"10.1055\/s-0034-1382790"},{"key":"786_CR179","doi-asserted-by":"crossref","unstructured":"Sabri SS, Saad WEA. Balloon-occluded retrograde transvenous obliteration (BRTO): technique and intraprocedural imaging. In: seminars in interventional radiology. \u00a9 Thieme Medical. 2011:303\u201313.","DOI":"10.1055\/s-0031-1284457"},{"key":"786_CR180","doi-asserted-by":"crossref","unstructured":"Saad WEA. Balloon-occluded retrograde transvenous obliteration of gastric varices: concept, basic techniques, and outcomes. In: seminars in interventional radiology. Thieme Medical. 2012:118\u201328.","DOI":"10.1055\/s-0032-1312573"},{"key":"786_CR181","doi-asserted-by":"crossref","unstructured":"Bothara SS, Parihar P, Patil R, Parihar P. Advancements in interventional radiology for managing hepatic encephalopathy: a comprehensive review. Cureus. 2024;16(6).","DOI":"10.7759\/cureus.62723"},{"issue":"8","key":"786_CR182","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.5966\/sctm.2015-0260","volume":"5","author":"M Najimi","year":"2016","unstructured":"Najimi M, Defresne F, Sokal EM. Concise review: updated advances and current challenges in cell therapy for inborn liver metabolic defects. Stem Cells Transl Med. 2016;5(8):1117\u201325.","journal-title":"Stem Cells Transl Med"},{"issue":"40","key":"786_CR183","doi-asserted-by":"publisher","first-page":"6757","DOI":"10.3748\/wjg.v19.i40.6757","volume":"19","author":"M Esrefoglu","year":"2013","unstructured":"Esrefoglu M. Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure. World J Gastroenterol. 2013;19(40):6757\u201373.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"786_CR184","first-page":"203","volume":"190","author":"S Gupta","year":"2000","unstructured":"Gupta S, Rajvanshi P, Irani AN, Palestro CJ, Bhargava KK. Integration and proliferation of transplanted cells in hepatic parenchyma following d-galactosamine\u2010induced acute injury in F344 rats. J Pathol J Pathol Soc Gt Br Irel. 2000;190(2):203\u201310.","journal-title":"J Pathol J Pathol Soc Gt Br Irel"},{"issue":"2","key":"786_CR185","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.intimp.2013.01.002","volume":"15","author":"N Wang","year":"2013","unstructured":"Wang N, Wang Z, Sun H, Shi X, Zhang Y, Liu Q. Augmenter of liver regeneration improves therapeutic effect of hepatocyte homotransplantation in acute liver failure rats. Int Immunopharmacol. 2013;15(2):325\u201332.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"786_CR186","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/146532400539305","volume":"2","author":"EM Horwitz","year":"2000","unstructured":"Horwitz EM, Keating A. The nonhematopoietic mesenchymal stem cell committee Workshop. nonhematopoietic mesenchymal stem cells: what are they? Cytotherapy. 2000;2(5):387\u20138.","journal-title":"Cytotherapy"},{"issue":"11","key":"786_CR187","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.molmed.2015.09.004","volume":"21","author":"B Christ","year":"2015","unstructured":"Christ B, Br\u00fcckner S, Winkler S. The therapeutic promise of mesenchymal stem cells for liver restoration. Trends Mol Med. 2015;21(11):673\u201386.","journal-title":"Trends Mol Med"},{"key":"786_CR188","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7015-10-56","volume":"10","author":"H Cao","year":"2012","unstructured":"Cao H, Yang J, Yu J, Pan Q, Li J, Zhou P, et al. Therapeutic potential of transplanted placental mesenchymal stem cells in treating Chinese miniature pigs with acute liver failure. BMC Med. 2012;10:1\u201320.","journal-title":"BMC Med"},{"issue":"3","key":"786_CR189","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/hep.25722","volume":"56","author":"J Li","year":"2012","unstructured":"Li J, Zhang L, Xin J, Jiang L, Li J, Zhang T, et al. Immediate intraportal transplantation of human bone marrow mesenchymal stem cells prevents death from fulminant hepatic failure in pigs. Hepatology. 2012;56(3):1044\u201352.","journal-title":"Hepatology"},{"issue":"10","key":"786_CR190","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1097\/MEG.0b013e32832a1f6c","volume":"21","author":"P Kharaziha","year":"2009","unstructured":"Kharaziha P, Hellstr\u00f6m PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I\u2013II clinical trial. Eur J Gastroenterol Hepatol. 2009;21(10):1199\u2013205.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10","key":"786_CR191","doi-asserted-by":"publisher","first-page":"725","DOI":"10.5966\/sctm.2012-0034","volume":"1","author":"M Shi","year":"2012","unstructured":"Shi M, Zhang Z, Xu R, Lin H, Fu J, Zou Z, et al. Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients. Stem Cells Transl Med. 2012;1(10):725\u201331.","journal-title":"Stem Cells Transl Med"},{"key":"786_CR192","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1007\/s12015-011-9322-y","volume":"8","author":"M El-Ansary","year":"2012","unstructured":"El-Ansary M, Abdel-Aziz I, Mogawer S, Abdel-Hamid S, Hammam O, Teaema S, et al. Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis. Stem Cell Rev Rep. 2012;8:972\u201381.","journal-title":"Stem Cell Rev Rep"},{"key":"786_CR193","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1440-1746.2011.07024.x","volume":"27","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Lin H, Shi M, Xu R, Fu J, Lv J, et al. Human umbilical cord mesenchymal stem cells improve liver function and Ascites in decompensated liver cirrhosis patients. J Gastroenterol Hepatol. 2012;27:112\u201320.","journal-title":"J Gastroenterol Hepatol"},{"key":"786_CR194","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/jgh.12029","volume":"28","author":"L Wang","year":"2013","unstructured":"Wang L, Li J, Liu H, Li Y, Fu J, Sun Y, et al. A pilot study of umbilical cord-derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis. J Gastroenterol Hepatol. 2013;28:85\u201392.","journal-title":"J Gastroenterol Hepatol"},{"key":"786_CR195","doi-asserted-by":"crossref","unstructured":"Gurunathan S, Kang MH, Kim JH. A comprehensive review on factors influences biogenesis, functions, therapeutic and clinical implications of exosomes. Int J Nanomed. 2021;1281\u2013312.","DOI":"10.2147\/IJN.S291956"},{"key":"786_CR196","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.bbi.2024.10.002","volume":"123","author":"YM Arenas","year":"2025","unstructured":"Arenas YM, P\u00e9rez-Martinez G, Montoliu C, Llansola M, Felipo V. Extracellular vesicles from L. paracasei improve neuroinflammation, GABA neurotransmission and motor incoordination in hyperammonemic rats. Brain Behav Immun. 2025;123:556\u201370.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"786_CR197","first-page":"3212643","volume":"2018","author":"M Ohara","year":"2018","unstructured":"Ohara M, Ohnishi S, Hosono H, Yamamoto K, Yuyama K, Nakamura H, et al. Extracellular vesicles from amnion-derived mesenchymal stem cells ameliorate hepatic inflammation and fibrosis in rats. Stem Cells Int. 2018;2018(1):3212643.","journal-title":"Stem Cells Int"},{"issue":"1","key":"786_CR198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-022-02688-4","volume":"20","author":"P Izquierdo-Altarejos","year":"2023","unstructured":"Izquierdo-Altarejos P, Cabrera-Pastor A, Mart\u00ednez-Garc\u00eda M, S\u00e1nchez-Huertas C, Hern\u00e1ndez A, Moreno-Manzano V, et al. Extracellular vesicles from mesenchymal stem cells reduce neuroinflammation in hippocampus and restore cognitive function in hyperammonemic rats. J Neuroinflammation. 2023;20(1):1.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"786_CR199","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11481-024-10153-7","volume":"19","author":"P Izquierdo-Altarejos","year":"2024","unstructured":"Izquierdo-Altarejos P, Mart\u00ednez-Garc\u00eda M, Atienza-P\u00e9rez I, Hern\u00e1ndez A, Moreno-Manzano V, Llansola M, et al. Extracellular vesicles from mesenchymal stem cells reverse neuroinflammation and restore motor coordination in hyperammonemic rats. J Neuroimmune Pharmacol. 2024;19(1):52.","journal-title":"J Neuroimmune Pharmacol"},{"key":"786_CR200","doi-asserted-by":"crossref","unstructured":"Izquierdo-Altarejos P, Arenas YM, Montoliu C, P\u00e9rez-Mart\u00ednez G, Llansola M, Felipo V. Extracellular vesicles from Lacticaseibacillus paracasei reduce neuroinflammation in hippocampus and restore some cognitive functions in hyperammonemic rats. Microbiol Res. 2025;128101.","DOI":"10.1016\/j.micres.2025.128101"},{"key":"786_CR201","doi-asserted-by":"publisher","unstructured":"Mincheva G, Manzano VM, Felipo V, Llansola M. Extracellular vesicles from mesenchymal stem cells improve neuroinflammation and neurotransmission in hippocampus and cognitive impairment in rats with mild liver damage and minimal hepatic encephalopathy. Stem Cell Res Ther [Internet]. 2024;6. Available from: https:\/\/doi.org\/10.1186\/s13287-024-04076-6","DOI":"10.1186\/s13287-024-04076-6"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00786-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-025-00786-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00786-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:11:48Z","timestamp":1768342308000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-025-00786-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":201,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["786"],"URL":"https:\/\/doi.org\/10.1007\/s43440-025-00786-7","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics consent to participate and consent to publish"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}